Understanding the economic, daily functioning, and diabetes management burden of non-severe nocturnal hypoglycemic events in Canada: Differences between type 1 and type 2

Journal of Medical Economics

Volumn 17, Issue 1, 2014, Pages 11-20

  Brod, Meryl ^a   Wolden, Michael ^b   Groleau, Danielle ^b   Bushnell, Donald M ^c  

^a Brod Group   (United States)

^b NOVO NORDISK A S   (Denmark)

^c Novo Nordisk Canada Inc ^*

Author keywords

Cost of illness; Diabetes mellitus; Diabetes type; Disease management; Functional burden; Nocturnal hypoglycemia

Indexed keywords

INSULIN; ORAL ANTIDIABETIC AGENT;

ADULT; ARTHRITIS; ARTICLE; BLOOD GLUCOSE MONITORING; CANADA; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DISEASE DURATION; DISEASE SEVERITY; FACE VALIDITY; FEMALE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEALTH SURVEY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NOCTURNAL HYPOGLYCEMIA; NON INSULIN DEPENDENT DIABETES MELLITUS; NON SEVERE NOCTURNAL HYPOGLYCEMIC; QUESTIONNAIRE; SELF REPORT; TELEPHONE INTERVIEW; TREATMENT DURATION; YOUNG ADULT;

ACTIVITIES OF DAILY LIVING; ADULT; AGED; AGED, 80 AND OVER; CANADA; COST OF ILLNESS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; FOCUS GROUPS; HEALTH SURVEYS; HUMANS; HYPOGLYCEMIA; MALE; MIDDLE AGED; QUALITATIVE RESEARCH; YOUNG ADULT;

EID: 84890535397     PISSN: 13696998     EISSN: 1941837X     Source Type: Journal    
DOI: 10.3111/13696998.2013.857676     Document Type: Article

References (34)

1. Canadian Diabetes Association Clinical Practice Guidelines Expert Committee. Hypoglycemia. Can J Diabetes 2008;32:S62-4
2. Brod M, Christensen T, Bushnell DM. The impact of non-severe hypoglycemic events on daytime function and diabetes management among adults with type 1 and type 2 diabetes. J Med Econ 2012;15:869-77
3. Brod M, Rana A, Barnett AH. Impact of self-treated hypoglycaemia in type 2 diabetes: a multinational survey in patients and physicians. Curr Med Res Opin 2012;28:1947-58
4. Brod M, Christensen T, Bushnell DM. Impact of nocturnal hypoglycemic events on diabetes management, sleep quality, and next-day function: results from a four-country survey. J Med Econ 2012;15:77-86
5. Unger J. Uncovering undetected hypoglycemic events. Diabetes Metab Syndr Obes 2012;5:57-74
6. Leiter LA, Yale JF, Chiasson JL, et al. Assessment of the impact of fear of hypoglycemic episodes on glycemic and hypoglycemia management. Can J Diabetes 2005;29:186-92
7. Gerstein HC, Miller ME, Genuth S, et al. Long-term effects of intensive glucose lowering on cardiovascular outcomes. N Engl J Med 2011;364:818-28
8. Brod M, Christensen T, Thomsen TL, et al. The impact of non-severe hypoglycemic events on work productivity and diabetes management. Value Health 2011;14:665-71
9. Brod M, Pohlman B, Wolden M, et al. Non-severe nocturnal hypoglycemic events: experience and impacts on patient functioning and well-being. Qual Life Res 2012;22:997-1004
10. Harris SB, Leiter LA, Yale JF, et al. Out-of-pocket costs of managing hyperglycemia and hypoglycemia in patients with type 1 diabetes and insulintreated type 2 diabetes. Can J Diabetes 2007;31:25-33
11. Willis WD, Diago-Cabezudo JI, Madec-Hily A, et al. Medical resource use, disturbance of daily life and burden of hypoglycemia in insulin-treated patients with diabetes: results from a European online survey. Expert Rev Pharmacoecon Outcomes Res 2013;13:123-30
12. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998;352:837-53
13. Garber A, Klein E, Bruce S, et al. Metformin-glibenclamide versus metformin plus rosiglitazone in patients with type 2 diabetes inadequately controlled on metformin monotherapy. Diabetes Obes Metab 2006;8:156-63
14. Pollack MF, Purayidathil FW, Bolge SC, et al. Patient-reported tolerability issues with oral antidiabetic agents: associations with adherence; treatment satisfaction and health-related quality of life. Diabetes Res Clin Pract 2010;87:204-10
15. Brod M, Wolden M, Christensen T, et al. Understanding the economic burden of non-severe nocturnal hypoglycemic events: impact on work productivity, disease management, and resource utilization. Value Health In press
16. Brod M, Wolden M, Christensen T, et al. A Nine-Country Study of the burden of non-severe nocturnal hypoglycaemic events on diabetes management and daily function. Diabetes Obes Metab 2013;15:546-57
17. Average hourly wages of employees by selected characteristics and profession, unadjusted data, by province (monthly), February 2012. CANISM tables 282-0069 and 282-0073. Statistics Canada. Ottawa, Ontario: Government of Canada, 2013. www.statcan.gc.ca/tables-tableaux/sum-som/l01/cst01/ labr69a-eng.htm. Accessed March 21, 2012
18. Dolovich L, Dahl M. Utilization and expenditure on blood glucose test strips in Canada. Can J Diabetes 2010;34:34-40
19. Endicott J, Nee J. Endicott Work Productivity Scale (EWPS): a new measure to assess treatment effects. Psychopharmacol Bull 1997;33:13-16
20. Cohen J. A power primer. Psychol Bull 1992;112:155-9
21. Roth T, Zammit G, Lankford A, et al. Nonrestorative sleep as a distinct component of insomnia. Sleep 2010;33:449-58
22. Low D, Gramlich M, Engram BW. Self-paced exercise program for office workers: impact on productivity and health outcomes. AAOHN J 2007;55:99-105
23. Beaton DE, Tang K, Gignac MA, et al. Reliability, validity, and responsiveness of five at-work productivity measures in patients with rheumatoid arthritis or osteoarthritis. Arthritis Care Res (Hoboken) 2010;62:28-37
24. Linden M, Baron S, Muschalla B. Relationship between work-related attitudes, performance and capacities according to the ICF in patients with mental disorders. Psychopathology 2010;43:262-7
25. da Silva JA, Phillips S, Buttgereit F. Impact of impaired morning function on the lives and well-being of patients with rheumatoid arthritis. Scand J Rheumatol Suppl 2011;125:6-11
26. Gettings L. Psychological well-being in rheumatoid arthritis: a review of the literature. Musculoskeletal Care 2010;8:99-106
27. Murphy L, Helmick CG. The impact of osteoarthritis in the United States: a population-health perspective. Am J Nurs 2012;112:S13-19
28. Fautrel B, Verstappen SM, Boonen A. Economic consequences and potential benefits. Best Pract Res Clin Rheumatol 2011;25: 607-24
29. The prevalence and costs of diabetes. Toronto, ON: Canadian Diabetes Association, 2012. www.diabetes.ca/diabetes-and-you/what/prevalence/. Accessed December 19, 2012
30. Older Adult Falls & Statistics. Atlanta, GA: Centers for Disease Control and Prevention, 2012. www.cdc.gov/homeandrecreationalsafety/Falls/data. html. Accessed September 17, 2012
31. The Harsh Reality - Diabetes is a Global Pandemic. Toronto, ON: Canadian Diabetes Association, 2012. www.diabetes.ca/diabetes-and-you/living/ harsh-reality/. Accessed December 19, 2012
32. Pijpers E, Ferreira I, de Jongh RT, et al. Older individuals with diabetes have an increased risk of recurrent falls: analysis of potential mediating factors: the Longitudinal Ageing Study Amsterdam. Age Ageing 2012;41:358-65
33. Pramming S, Thorsteinsson B, Bendtson I, et al. Symptomatic hypoglycaemia in 411 type 1 diabetic patients. Diabet Med 1991;8:217-22
34. Canada. The World Factbook. Washington, DC: US Central Intelligence Agency, 2012. www.cia.gov/library/publications/the-world-factbook/. Accessed July 30, 2012